Hong Kong Wound Dressing Market to Cross $70.6 Million Revenue by 2030, says P&S Intelligence

NEW YORK – From $40.1 million in 2020, the Hong Kong wound dressing market size is projected to increase to $70.6 million by 2030, at a 6.0% CAGR between 2021 and 2030.

The major reasons behind the growing demand for products are:

Booming Geriatric Population: According to the Chinese University of Hong Kong, people aged 65 and above will make up 27% of the metropolis’ population by 2033, compared to 11.7% in 2003. Such people often injure themselves, getting nasty wounds. Additionally, they suffer from many chronic diseases that lead to wounds, thereby propelling the market growth.

Rising Diabetes Prevalence: The increasing cases of diabetes are also driving the Hong Kong wound dressing market as the disease often leads to diabetic foot ulcers, a type of chronic wound, which is hard to cure using traditional methods. A key reason behind the increasing diabetes incidence in the megacity is the rising number of obese people, as obesity is a major risk factor for this endocrine disorder.

The COVID-19 pandemic has affected the Hong Kong wound dressing market negatively as the lockdowns confined people inside their homes. This led to a major reduction in the incidence of road accidents and injuries among school and college students. In the same way, the closed surgery departments resulting in a low incidence of surgical wounds, thereby further pushing down the demand for wound dressing products.

In the coming years, the advanced bifurcation will witness the faster growth in the Hong Kong wound dressing market, within the type segment. Advanced wound dressings allow for rapid healing, temperature and moisture control around the wound, gaseous exchange, infection inhibition, and tissue regeneration.

The chronic wounds bifurcation held the larger share in the application segment of the Hong Kong wound dressing market in the past. Such wounds are long lasting and difficult to treat, which is why they require frequent changes of the dressing, preferably advanced dressing.

In the near future, the Hong Kong wound dressing market, under the end user segment, will be dominated by the hospitals & specialty clinics category. As such medical facilities employ experienced professionals and boast advanced equipment, people, especially trauma and burn victims, prefer them for getting their wounds dressed.

The pharmacies category generated the highest revenue in the Hong Kong wound dressing market historically, based on distribution channel. Being dedicated to pharma and other healthcare-related products, pharmacies offer a wide variety of traditional and advanced dressings for wounds.

Major players in the Hong Kong wound dressing market are Coloplast A/S, Paul Hartmann AG, 3M Company, Winner Medical Co. Ltd., Smith & Nephew plc, Mölnlycke Health Care AB, ConvaTec Group plc, Zhende Medical Co. Ltd., Allmed Medical Products Co. Ltd., Wayson Medical Co. Ltd., Essity AB, B. Braun Melsungen AG, Beiersdorf AG, Urgo Medical, Johnson & Johnson, Cardinal Health Inc., Integra LifeSciences Holdings Corporation, Medtronic plc, Wright Medical Group N.V., Lohmann & Rauscher GmbH & Co. KG, Medela AG, Weigao Group Co. Ltd., and Nitto Denko Corporation

Exit mobile version